| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alzamend Neuro, Inc. (ALZN) has 3 insiders with recent SEC Form 4 filings, including 25 buys and 1 sell. ALZN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 25 | $30.50 | - | |
| Dir | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2021 | Ault Milton C III | 10% Owner | Buy | 16,400 | $3.62 | $59,378.66 | +0.1% | -31.0% | -70.4% | |
| Aug 10, 2021 | Ault Milton C III | 10% Owner | Buy | 5,600 | $4.06 | $22,714.58 | - | -35.9% | -74.9% | |
| Aug 5, 2021 | Ault Milton C III | 10% Owner | Buy | 1,500 | $4.24 | $6,360.45 | - | -48.3% | -77.3% | |
| Aug 3, 2021 | Ault Milton C III | 10% Owner | Buy | 1,340,333 | $1.52 | $2,031,862.95 | +5.6% | -50.5% | -78.7% | |
| Jul 27, 2021 | Ault Milton C III | 10% Owner | Buy | 12,500 | $5.08 | $63,553.60 | - | -50.2% | -80.2% | |
| Jul 21, 2021 | Ault Milton C III | 10% Owner | Buy | 3,500 | $5.24 | $18,331.70 | - | -59.0% | -82.8% | |
| Jul 19, 2021 | Ault Milton C III | 10% Owner | Buy | 5,300 | $5.63 | $29,817.76 | - | -57.1% | -82.4% | |
| Jul 15, 2021 | Ault Milton C III | 10% Owner | Sell | 300 | $6.92 | $2,076.09 | - | -64.6% | -86.7% | |
| Jul 14, 2021 | Ault Milton C III | 10% Owner | Buy | 14,000 | $6.37 | $89,135.73 | - | -61.5% | -85.4% | |
| Jul 8, 2021 | Ault Milton C III | 10% Owner | Buy | 14,000 | $6.65 | $93,109.30 | - | -58.3% | -84.4% |